Special Issue "Autism Spectrum Disorder and Epilepsy"
Deadline for manuscript submissions: 10 February 2024 | Viewed by 4868
2. Southwest Autism Research and Resource Center, Phoenix, AZ 85006, USA
3. Autism Discovery and Treatment Foundation, Phoenix, AZ 85050, USA
Interests: neurodevelopment disorders; metabolic disorders; autism; mitochondrial disorders; folate metabolism; redox metabolism
Special Issues, Collections and Topics in MDPI journals
Special Issue in Journal of Personalized Medicine: A Personalized Medicine Approach to the Diagnosis and Management of Autism Spectrum Disorder: 2022
Special Issue in Journal of Personalized Medicine: A Personalized Medicine Approach to the Diagnosis and Management of Autism Spectrum Disorder: Beyond Genetic Syndromes
Special Issue in Journal of Personalized Medicine: EEG Research in Psychiatry: A Step towards Precision Medicine in Mental Health
Interests: pediatric brain malformations; epilepsy; neurology; neurophysiology
2. Translational Neuroscience, Mind Research Network, Albuquerque, NM 87106, USA
3. Department of Neurology, University of New Mexico, Albuquerque, NM 87114, USA
4. Department of Psychology, University of New Mexico, Albuquerque, NM 87114, USA
5. Beyond Barriers Therapeutics, Glendale, IL 60612, USA
Interests: autism spectrum disorders; epilepsy; traumatic brain injury; post-traumatic stress disorder; structural and functional brain imaging and electrophysiology
Background: Autism spectrum disorder (ASD) now affects more than 2% of children, with its prevalence continuing to grow. Epilepsy is one of the most common comorbid conditions associated with ASD, and it results in significant disability in those that it effects. Most significantly, epilepsy is associated with lower overall function and behavioral issues in those with ASD, and it is more difficult to control. Furthermore, it has been found to be a source of significant mortality in individuals with ASD. At present, current therapies provide suboptimal control of seizures, resulting in increased disability. Many of the underlying genetic and metabolic conditions that are associated with ASD can also result in epilepsy, leading to the possibility that a greater understanding of the underlying cause and treatment for epilepsy in those with ASD is possible. Thus, we aim to publish papers in this Special Issue that provide greater insight into epilepsy in ASD in order to provide a more personalized approach to the evaluation and treatment of epilepsy in ASD.
Aim and scope: Our goal is to publish high-impact articles describing a personalized medicine approach to the diagnosis, classification, and treatment of epilepsy in those with ASD. This includes the role of metabolic disorders, environmental factors, and the contribution to genetic variants and vulnerabilities and their interaction with the environment.
History: Individuals with ASD and epilepsy are often inadequately treated as the treatment response is extremely variable and biomarkers used to predict response are limited. Thus, a personalized medicine approach could greatly benefit this population.
Cutting-edge research: We encourage any submissions that improve the understanding of epilepsy in ASD, including the roles of genetic, epigenetic, physiologic, metabolic, immunological, and microbiome factors that are involved in the management and treatment of individuals with ASD and epilepsy.
What types of papers we are soliciting: We encourage the submission of manuscripts describing a personalized medicine approach to the diagnosis, classification, and treatment of individuals with ASD and epilepsy, particularly with respect to factors that will improve treatment outcomes.
Prof. Dr. Richard E. Frye
Dr. John N. Gaitanis
Dr. Jeffrey David Lewine
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- autism spectrum disorder
- metabolic disorders
- microbiome environmental factors